EP1877004A4 - Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree - Google Patents

Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree

Info

Publication number
EP1877004A4
EP1877004A4 EP06739478A EP06739478A EP1877004A4 EP 1877004 A4 EP1877004 A4 EP 1877004A4 EP 06739478 A EP06739478 A EP 06739478A EP 06739478 A EP06739478 A EP 06739478A EP 1877004 A4 EP1877004 A4 EP 1877004A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
long
medical devices
term efficacy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP06739478A
Other languages
German (de)
English (en)
Other versions
EP1877004A2 (fr
Inventor
John K Toner
Sandra E Burke
Keith R Cromack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to EP16171630.3A priority Critical patent/EP3138531A1/fr
Publication of EP1877004A2 publication Critical patent/EP1877004A2/fr
Publication of EP1877004A4 publication Critical patent/EP1877004A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
EP06739478A 2005-03-23 2006-03-22 Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree Ceased EP1877004A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16171630.3A EP3138531A1 (fr) 2005-03-23 2006-03-22 Compositions et procédés d'administration d'analogues de rapamycine au moyen de dispositifs médicaux pour une efficacité à long terme

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US66448805P 2005-03-23 2005-03-23
US71508205P 2005-09-08 2005-09-08
US72708005P 2005-10-14 2005-10-14
US72687805P 2005-10-14 2005-10-14
US72719605P 2005-10-14 2005-10-14
US73257705P 2005-10-17 2005-10-17
PCT/US2006/010700 WO2007032777A2 (fr) 2005-03-23 2006-03-22 Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP16171630.3A Division EP3138531A1 (fr) 2005-03-23 2006-03-22 Compositions et procédés d'administration d'analogues de rapamycine au moyen de dispositifs médicaux pour une efficacité à long terme

Publications (2)

Publication Number Publication Date
EP1877004A2 EP1877004A2 (fr) 2008-01-16
EP1877004A4 true EP1877004A4 (fr) 2012-01-25

Family

ID=37865406

Family Applications (2)

Application Number Title Priority Date Filing Date
EP16171630.3A Withdrawn EP3138531A1 (fr) 2005-03-23 2006-03-22 Compositions et procédés d'administration d'analogues de rapamycine au moyen de dispositifs médicaux pour une efficacité à long terme
EP06739478A Ceased EP1877004A4 (fr) 2005-03-23 2006-03-22 Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP16171630.3A Withdrawn EP3138531A1 (fr) 2005-03-23 2006-03-22 Compositions et procédés d'administration d'analogues de rapamycine au moyen de dispositifs médicaux pour une efficacité à long terme

Country Status (3)

Country Link
EP (2) EP3138531A1 (fr)
JP (1) JP5242374B2 (fr)
WO (1) WO2007032777A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378105B2 (en) 1997-09-26 2008-05-27 Abbott Laboratories Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens
US8257726B2 (en) 1997-09-26 2012-09-04 Abbott Laboratories Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
US8394398B2 (en) * 1997-09-26 2013-03-12 Abbott Laboratories Methods of administering rapamycin analogs with anti-inflammatories using medical devices
US7357942B2 (en) 1997-09-26 2008-04-15 Abbott Laboratories Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens
US8431145B2 (en) 2004-03-19 2013-04-30 Abbott Laboratories Multiple drug delivery from a balloon and a prosthesis
EP2068932B1 (fr) * 2006-08-15 2013-11-06 Abbott Laboratories Compositions et systèmes d'administration de médicament comprenant des analogues de la rapamycine et du paclitaxel
US8409272B2 (en) 2007-09-04 2013-04-02 Japan Stent Technology Co., Ltd. Sustained drug-releasing stent
US8951595B2 (en) 2009-12-11 2015-02-10 Abbott Cardiovascular Systems Inc. Coatings with tunable molecular architecture for drug-coated balloon
US20130303496A1 (en) * 2012-05-08 2013-11-14 Abbott Cardiovascular Systems Inc. Method Of Treating Vascular Lesions
US9610385B2 (en) * 2013-03-07 2017-04-04 Abbott Cardiovascular Systems Inc. Method of fabricating an implantable medical device comprising a rapamycin derivative
KR20230150790A (ko) * 2020-12-29 2023-10-31 시노 메디칼 사이언시즈 테크놀로지, 인코포레이티드 약물 용출 스텐트

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001087372A1 (fr) * 2000-05-12 2001-11-22 Cordis Corporation Combinaisons de medicaments utiles pour la prevention de la restenose
WO2002062335A2 (fr) * 2001-01-16 2002-08-15 Vascular Therapies, Llc Appareil et methodes de prevention ou de traitement en cas d'echec d'un acces vasculaire pour hemodialyse et en cas de rejet de greffons vasculaires
WO2003022807A2 (fr) * 2001-09-10 2003-03-20 Abbott Laboratories Dispositifs medicaux contenant des analogues de rapamycine
WO2004022124A1 (fr) * 2002-09-06 2004-03-18 Abbott Laboratories Dispositif medical comprenant un inhibiteur d'hydratation
WO2005092406A1 (fr) * 2004-03-22 2005-10-06 Advanced Cardiovascular Systems, Inc. Compositions de revetement de phosphorylcholine

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3993749A (en) 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4885171A (en) 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4401653A (en) 1981-03-09 1983-08-30 Ayerst, Mckenna & Harrison Inc. Combination of rapamycin and picibanil for the treatment of tumors
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US4650803A (en) 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US5527337A (en) 1987-06-25 1996-06-18 Duke University Bioabsorbable stent and method of making the same
US4916193A (en) 1987-12-17 1990-04-10 Allied-Signal Inc. Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US5092877A (en) 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
WO1991017724A1 (fr) 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Polymere utilise dans un dispositif medical
JPH04230389A (ja) 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
US5023262A (en) 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5120725A (en) 1991-05-29 1992-06-09 American Home Products Corporation Bicyclic rapamycins
US5120727A (en) 1991-05-29 1992-06-09 American Home Products Corporation Rapamycin dimers
US6090901A (en) 1991-07-05 2000-07-18 Biocompatibles Limited Polymeric surface coatings
US5705583A (en) 1991-07-05 1998-01-06 Biocompatibles Limited Polymeric surface coatings
US5163852A (en) 1992-02-11 1992-11-17 W. L. Gore & Associates, Inc. Coaxial cable side tape connector assembly and processes for assembly
US5177203A (en) 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5605696A (en) 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
ATE435680T1 (de) 1997-03-31 2009-07-15 Igaki Iryo Sekkei Kk Stent für gefässe
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
GB0100760D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US7708712B2 (en) * 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
JPWO2005011796A1 (ja) * 2003-08-05 2006-09-14 株式会社カネカ 生体留置用ステント
JP4379044B2 (ja) * 2003-08-22 2009-12-09 株式会社カネカ 生体留置用ステント
AU2005269718A1 (en) * 2004-07-19 2006-02-09 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001087372A1 (fr) * 2000-05-12 2001-11-22 Cordis Corporation Combinaisons de medicaments utiles pour la prevention de la restenose
WO2002062335A2 (fr) * 2001-01-16 2002-08-15 Vascular Therapies, Llc Appareil et methodes de prevention ou de traitement en cas d'echec d'un acces vasculaire pour hemodialyse et en cas de rejet de greffons vasculaires
WO2003022807A2 (fr) * 2001-09-10 2003-03-20 Abbott Laboratories Dispositifs medicaux contenant des analogues de rapamycine
WO2004022124A1 (fr) * 2002-09-06 2004-03-18 Abbott Laboratories Dispositif medical comprenant un inhibiteur d'hydratation
WO2005092406A1 (fr) * 2004-03-22 2005-10-06 Advanced Cardiovascular Systems, Inc. Compositions de revetement de phosphorylcholine

Also Published As

Publication number Publication date
WO2007032777A3 (fr) 2007-10-25
WO2007032777A2 (fr) 2007-03-22
EP1877004A2 (fr) 2008-01-16
JP5242374B2 (ja) 2013-07-24
EP3138531A1 (fr) 2017-03-08
JP2008534074A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
EP1877004A4 (fr) Compositions et procedes pour l'administration d'analogues de rapamycine au moyen de dispositifs medicaux pour une efficacite de longue duree
EP1933760A4 (fr) Compositions et methodes d'administration d'analogues de rapamycine avec du paclitaxel a l'aide de dispositifs medicaux
EP2004175A4 (fr) Composés augmentant l'activité anticancéreuse, formulations les contenant et leurs méthodes d'utilisation
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL195237A0 (en) Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
IL184735A0 (en) Pharmaceutical formulations and methods of use
ZA200900345B (en) Preparation of pharmaceutical formulations
EP2174667A4 (fr) Agent pour le traitement de l'ophtalmie contenant un inhibiteur du récepteur de l'interleukine 6 en tant qu'ingrédient actif
IL202684A0 (en) Anti-cd20 therapeutic compositions and methods of use thereof
GB0524958D0 (en) Transdermal administration of active agents
IL198723A0 (en) Methods and compositions for therapeutic treatment
HK1142823A1 (en) Formulations for the oral administration of therapeutic agents and related methods
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1906941A4 (fr) Procedes de traitement de blessures au moyen de compositions programmables
EP1740541A4 (fr) Formulations therapeutiques de desoxyepothilones
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
EP2096927A4 (fr) Compositions thérapeutiques et procédés de traitement avec des composés de type capsianoside
IL194066A0 (en) Therapeutic composition for treatment of tinnitus
EP2077847A4 (fr) Di- et trisaccharides alkylés et halogénés et préparations pharmaceutiques, trousses de diagnostic et méthodes de traitement associées
EP1962882A4 (fr) Préparations et méthodes pour le traitement du diabète
ZA200710476B (en) Methods and compositions for the treatment of pain
EP1933624A4 (fr) Compositions et methodes de traitement de l'hypersecretion des voies respiratoires
GB0610207D0 (en) New forms of active pharmaceutical ingredient
ZA200806668B (en) Antiseptic compositions and methods of using same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071022

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20111228

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 2/00 20060101AFI20111221BHEP

Ipc: A61K 31/44 20060101ALI20111221BHEP

Ipc: A61L 31/16 20060101ALI20111221BHEP

17Q First examination report despatched

Effective date: 20130327

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20160924